Latest chemotherapy Stories
Would Become First EMA-approved Therapy for Patients in Europe SUNNYVALE, Calif., May 22, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
Ethics Boards at Three Hospitals in Germany Approve Trial Expansion NEW YORK, May 21, 2015 /PRNewswire/ -- Delcath Systems, Inc.
WESTON, Fla., May 18, 2015 /PRNewswire/ -- Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications
A three-year $717,000 grant from the National Cancer Institute will help researchers begin to study the effectiveness of using saliva samples to alert physicians of potentially toxic levels of
Company demonstrates dedication to rare cancers WOODCLIFF LAKE, N.J., May 14, 2015 /PRNewswire/ -- Eisai Inc.
Anti-tumor effect in mice with human melanoma cells SYDNEY, May 14, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen (NRT:ASX; NVGN: NASDAQ), today
Study Results will be presented at the American Society of Clinical Oncology Annual Meeting in Chicago LONDON, May 14, 2015 /PRNewswire/ -- Immodulon Therapeutics today announced updated
CorrectChemo® Test to be Offered as Part of Cancer Management Solutions Nashville, Tennessee (PRWEB) May 12, 2015 DiaTech Oncology, provider of
REDWOOD CITY, Calif., May 11, 2015 /PRNewswire/ -- Genomic Health (Nasdaq: GHDX) today announced that the 14th St.
Scientists from two top Texas medical centers say the radiation technique known as IMRT can help mesothelioma patients live longer after surgery – as long as the dose is carefully managed.
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...